Abstract:Abstract Hereditary spastic paraplegias (HSPs) are characterized by lower limb spasticity resulting from degeneration of long corticospinal axons. SPG11 is one of the most common autosomal recessive HSPs, and the SPG11 protein spatacsin forms a complex with the SPG15 protein spastizin and heterotetrameric AP5 adaptor protein complex, which includes the SPG48 protein AP5Z1. Using the integration-free episomal method, we established SPG11 patient-specific induced pluripotent stem cells (iPSCs) from patient fibroblasts. We differentiated SPG11 iPSCs, as well as SPG48 iPSCs previously established, into cortical projection neurons (PNs) and examined protective effects by targeting mitochondrial dynamics using P110, a peptide that selectively inhibits mitochondrial fission GTPase Drp1. P110 treatment mitigates mitochondrial fragmentation, improves mitochondrial motility, and restores mitochondrial health and ATP levels in SPG11 and SPG48 neurons. Neurofilament (NF) aggregations are increased in SPG11 and SPG48 axons, and these are also suppressed by P110. Similarly, P110 mitigates NF disruption in both SPG11 and SPG48 knockdown cortical PNs, confirming the contribution of HSP gene deficiency to subsequent NF and mitochondrial defects. Strikingly, NF aggregations in SPG11 and SPG48 deficient neurons double stain with ubiquitin and autophagy related proteins, resembling the pathological hallmark observed in SPG11 autopsy brain sections. To confirm the cause-effect relationship between the SPG11 mutations and disease phenotypes, we knocked-in SPG11 disease mutations to human embryonic stem cells (hESCs) and differentiated these stem cells into cortical PNs. Reduced ATP levels and accumulated NF aggregations along axons are observed, and both are mitigated by P110. Furthermore, rescue experiment with expression of wildtype SPG11 in cortical PNs derived from both SPG11 patient iPSCs and SPG11 disease mutation knock-in hESCs leads to rescue of mitochondrial dysfunction and NF aggregations in these SPG11 neurons. Finally, in SPG11 and SPG48 long-term cultures, increased release of phosphoNF-H, a biomarker for nerve degeneration, is significantly reduced by inhibiting mitochondrial fission pharmacologically using P110 and genetically using Drp1 shRNA. Taken together, our results demonstrate that impaired mitochondrial dynamics underlie both cytoskeletal disorganization and axonal degeneration in SPG11 and SPG48 neurons, highlighting the importance of targeting these pathologies therapeutically.

A major disease-related point mutation in spastin alters dramatically the dynamics and allostery of the motor

Novel Mutations in the SPAST Gene Cause Hereditary Spastic Paraplegia.

Mutation of Spastin Affects Microtubule Dynamics Through Differential Distribution

[Spastin Gene Mutation in Chinese Patients with Hereditary Spastic Paraplegia].

Molecular and Cellular Mechanisms of Spastin in Neural Development and Disease (Review)

A Novel SPAST Mutation Results in Spastin Accumulation and Defects in Microtubule Dynamics

Structural and functional role of residues undergoing hereditary spastic paraplegias-linked mutations: insights from a simulation of the spiral to ring transition in katanin

FBXL17/spastin axis as a novel therapeutic target of hereditary spastic paraplegia

Effect of spastic paraplegia mutations in KIF5A kinesin on transport activity

How a pathogenic mutation impairs Hsp60 functional dynamics from monomeric to fully assembled states

Spastin accumulation and motor neuron defects caused by a novel SPAST splice site mutation

Spastin regulates ER-mitochondrial contact sites and mitochondrial homeostasis

Phosphorylation of Spastin Promotes the Surface Delivery and Synaptic Function of AMPA Receptors

Inhibiting mitochondrial fission rescues degeneration in hereditary spastic paraplegia neurons

Axon demyelination and degeneration in a zebrafish spastizin model of hereditary spastic paraplegia

Atlastin-1 regulates endosomal tubulation and lysosomal proteolysis in human cortical neurons

Characterization of human small heat shock protein HSPB1 α-crystallin domain localized mutants associated with hereditary motor neuron diseases

A novel missense mutation in SPAST causes hereditary spastic paraplegia in male members of a family: A case report

Cul-4 inhibition rescues spastin levels and reduces defects in hereditary spastic paraplegia models

Theoretical Investigations of the Role of Mutations in Dynamics of Kinesin Motor Proteins

The AAA Protein Spastin Possesses Two Levels of Basal ATPase Activity.